Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

Funding Opportunities

Extramural Grant Review Opportunity Available

Writing a grant? Need another set of eyes?

The Masonic Cancer Center Science Council can appoint individuals to review cancer center faculty members' grant drafts* or grant ideas in a face-to-face setting or in writing, depending on the stage of grant development. The goal is to improve upon members' success in obtaining grants funded by the NCI, ACS, and other national cancer research organizations.

To request a review, contact Elizabeth Fedie, efedie@umn.edu, 624-0653.

*Members should submit their ideas or abstracts and specific aims one cycle (~3-4 months minimum) before the grant is due. We will usually provide feedback within 1 week.

News and Notices  

Reminder: Biosketch Requirements for Due Dates On or After May 25, 2015
Remember, the modified biosketch format is required for applications submitted to NIH for due dates on or after May 25, 2015. Biosketch format pages, instructions, samples and FAQs are available on the Biosketches section of the SF424 (R&R) Forms and Applications page.

Epic and Research: Review of Research Workflows and Tools Seminar
Clinical and Translational Science Institute, UMN
April 8, 3:30-4:30pm, Moos 2-620

Clinical Trial Management Systems and OnCore Implementation Essentials Seminar
Clinical and Translational Science Institute, UMN
April 28, 10:30-11:30am, Moos 2-520

NIH Fiscal Policy for Grant Awards - FY2015
(NOT-OD-15-050)
National Institutes of Health

NIH Increases Salary Cap to $183,300
(NOT-OD-15-049)
National Institutes of Health

Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2015
(NOT-OD-15-048)
National Institutes of Health

Funding Opportunities  

JUST RELEASED!  FY15 DOD OCRP
Recently released funding opportunities are available now for the Ovarian Cancer Research Program:

  • Clinical Translational Award
  • Investigator-Initiated Research Award
  • Ovarian Cancer Academy – Early-Career Investigator Award (new eligibility criteria for FY15)
  • Pilot Award
    Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements.

ACS Institutional Research Grants

Due Date: April 15, 2015
American Cancer Society Institutional Research Grant applications are being accepted until April 20, 2015. This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes cancer etiology, mechanisms of carcinogenesis and chemoprevention, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic or chemoprevention models and translational research, cancer immunology and immunotherapy.

This is a one-year seed grant. Funding is available up to $30,000. Applications may be obtained by emailing a request to fauts001@umn.edu. For information, please call Susan Fautsch, 612-625-6238.

Faculty Scholars Program
The Bill & Melinda Gates Foundation and the Simons Foundation have joined forces with HHMI to support the Faculty Scholars program. Through this first-time collaboration, the program partners will augment and secure the pipeline of scientific talent. The Faculty Scholars program seeks to provide financial support to faculty at an early career stage, select awardees based on their vision and potential for unique contributions, and offer mentoring and career development.
Application Due: July 28th, 2015
Funding: 5 year awards, ranging from $100,000-$400,000 per year.

Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.

CTSI Dissemination & Implementation Awards Program
Clinical and Translational Science Institute, UMN
This program provides funding to research teams so they can apply research to the real world, with the ultimate goal of improving human health. Proposals require collaboration between University researchers and Minnesota-based community organizations.
This program will award a total of $20,000 to 6-12 collaborative research teams (individual awards range from $500-$4,000) to support the dissemination and implementation of evidence-based health strategies into our communities.
Proposals Due: April 27th, 2015

New research career development opportunities for junior faculty from CTSI
Due May 14th, 2015

New Investigator Pre-K Career Development Program
Supports assistant professors (rank <4 years) interested in clinical or translational research
Offers $52,000 in research and travel funds, to be expended over 2 years
Aims to put new investigators on the path to be competitive for NIH K awards

KL2 Scholars Career Development Program
Supports assistant professors (rank < 6 years) conducting clinical and translational research
Offers 75% salary support and up to $26,000/year in research and travel funds for 3 years
Aims to support investigators as they work toward a goal of securing independent NIH funding

K to R01 Transition to Independence Program
Supports assistant professors (rank < 7 years) who have active K awards for < 4 years at the time of application
Offers $50,000 in research funds to be expended over two years
Designed to place junior investigators further on the path to be competitive for R01 awards

American Cancer Society Funding Opportunities (PDF)
News Release: Announcement for Funding Opportunities for Cancer Research,
Training, and Career Development – Oct. 15th Deadline

ASSIST To Become an Option for Submission of Applications for Most Competing Grant Programs in 2015
(NOT-OD-15-044)

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)
(PAR-15-075)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
Funding: Standard R01 limits apply

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)
(PAR-15-064)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: $100,000/yr towards salary; $30,000/yr for other expenses

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08)
(PAR-15-060)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: $100,000/yr towards salary; $30,000/yr for other expenses

NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)
(PAR-15-062)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: $100,000/yr towards salary; $30,000/yr for other expenses

New RFA to Support Research Projects with Commercial Potential
The new Translational Product Development Fund program is now accepting applications from investigators at the University and the Mayo Clinic, and will award funded projects up to either $50,000 or $200,000. The program supports projects that intend to develop a novel therapeutic compound (i.e., drug, small molecule, or biologic), device, diagnostic, or IT product, and have the potential to be commercialized. The Clinical and Translational Science Institute (CTSI) and the Mayo Clinic Center for Clinical and Translational Science (CCaTS) established the program in conjunction with the Minnesota Partnership for Biotechnology and Medical Genomics. Mandatory letters of intent (LOIs) are due by 5pm on December 19, 2014 (Cycle 1) and May 1, 2015 (Cycle 2).

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) 
(PAR-15-053)
National Cancer Institute
Application Receipt/Submission Date(s): June 22, 2015; November 30, 2015; see announcement for additional dates.
Funding: Standard R21 limits apply.

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01)
(PAR-15-021)
National Cancer Institute
Application Receipt Date(s): November 25, 2015; see announcement for additional dates
Funding: $500,000 per year for 5 years

National Cancer Institute Program Project Applications (P01)
(PAR-15-023)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Varies.

Environmental Influences during Windows of Susceptibility in Breast Cancer Risk (U01)
(RFA-ES-14-012)
National Cancer Institute
Application Receipt Date(s): January 28, 2015
Funding: $600,000/yr for 5 years

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50)
(PAR-14-353)
National Cancer Institute
Application Receipt Date(s): May 19, 2015; September 22, 2015; January 27, 2016; May 19, 2016; September 22, 2016
Funding: $2,300,000 total costs/year

Advancing Interventions to Improve Medication Adherence
PA-14-334 – R01
PA-14-335 – R21
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard R01 & R21 limit

Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)
(PAR-14-242)
National Cancer Institute
Application Receipt Date(s):  See announcement for dates.
Funding: Standard R01 limits apply.

Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)
(PAR-14-260)
National Cancer Institute
Application Receipt Date(s): May 12, 2016, See announcement for additional dates.
Funding: Standard R01 limits apply.

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33)
(PAR-14-230)
National Cancer Institute
Application Receipt Date(s): April 15, 2015, August 17, 2015, December 15, 2015. See announcement for additional deadlines.
Funding: The R21 phase may not exceed two years or $275,000 in direct costs, with no more than $150,000 in direct costs in any single year of the R21 phase.  The R33 phase may not exceed three years or $450,000 in direct costs, with no more than $225,000 in direct costs in any single year of the R33 phase.

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33)
(PAR-14-230)
National Cancer Institute
Application Receipt Date(s):  April 15, 2015, August 17, 2015, December 15, 2015. See announcement for additional deadlines.
Funding: The R21 phase may not exceed two years or $275,000 in direct costs, with no more than $150,000 in direct costs in any single year of the R21 phase.  The R33 phase may not exceed three years or $450,000 in direct costs, with no more than $225,000 in direct costs in any single year of the R33 phase.

Predoctoral Training in Biomedical Big Data Science (T32)
(RFA-HG-14-004)
National Cancer Institute
Application Receipt Date(s): July 27, 2015, by 5:00 PM local time of applicant organization.
Funding: Average size budget of $350,000/yr total costs for 5 years

Genomic Resource Grants for Community Resource Projects (U41)
(
PAR-14-191)
National Cancer Institute
Application Receipt Date(s): May 25, 2015; September 25, 2015; January 25, 2016; May 25, 2016; September 25, 2016; January 25, 2017 
Funding: 5 years of funding.  Application budgets are not limited, but should reflect the needs of the proposed project.

THE U OF M INFORMATICS INSTITUTE (UMII) has announced two major funding initiatives at the interface of informatics and its applications: the UMII Transdisciplinary Research Fellowship will position recently promoted associate professors to provide leadership in transdisciplinary collaborative projects, and the UMII Faculty in Industry Fellowship will enable faculty to build strong partnerships with Minnesota businesses or agencies to develop long-term projects that address critical societal challenges. For more information, see UMII .

Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)
(PA-14-114)
National Cancer Institute
Funding: Standard R01 limits apply.
Application Receipt Date(s): Multiple dates, see announcement. 

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)
(PAR-14-013)
National Cancer Institute
Funding: Standard R21 limits apply
Deadline: See announcement for dates. 

Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)
(PAR-14-116)
National Cancer Institute
Funding: $500,000/yr for 5 years
Application Receipt Date(s): Multiple dates, see announcement 

Modeling Social Behavior (R01)

(PAR-13-374)
National Cancer Institute
Deadline: Multiple dates, see announcement.
Funding: Standard R01 limits apply.

Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
(PAR-13-375)
National Cancer Institute
Deadline: March 22, 2016
Funding: Standard R01 limits apply.

TTR Core Usage Funding Program
Sponsor: Office of Discovery and Translation - CTSI
Application Deadline (ongoing): 5 p.m. on the 10th day of any month
Funding: up to $10,000 to use a TTR-designated Core Resource for up to one year
The Core Usage Funding Program is designed to support clinical or translational projects. Basic research projects are ineligible. The supported studies may be either pilot projects, intended to generate preliminary data for larger studies, or projects nearing the final stages of completion but now require additional data the Core Resources can generate. It is expected that a Core Usage grant will be used to generate data to support an external grant submission or patent application.

Pancreatic Cancer Action Network Research Grants Program
Sponsor: Pancreatic Cancer Action Network and American Association for Cancer Research
Deadlines: Multiple; see announcement
Funding: See announcement
Funding is available for postdoctoral/clinical research fellows as well as for junior and senior independent researchers. The proposed research must be directly relevant to pancreatic cancer. More information about the grants program, including eligibility criteria and application due dates and procedures, is available at http://www.pancan.org/2014grants.. 

Research to Characterize and Reduce Stigma to Improve Health
R01 (PA-13-248)
R03 (PA-13-247)
R21 (PA-13-246)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.  Standard cycle dates.
Funding: Standard limits apply

Prostate Cancer Research Program (PCRP)
Sponsor: Department of Defense
Deadlines: Various; see announcements
Funding: See announcements

Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness
R01 (PA-13-165)
R15 (PA-13-166)
R21 (PA-13-167)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard limits apply. See announcements for additional information.

Bioengineering Research Grants (BRG) (R01)
(PAR-13-137)
National Cancer Institute
Application Deadline: Multiple receipt dates, see announcement. 
Funding: Standard R01 limits apply

Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)
(PAR-13-169)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: standard R01 limits apply       

 

 

Research Funding Resources
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on April 6, 2015